The "Pfizer of Medical Marijuana" Could Be In for Another Round of 1,000%+ Gains

Legal marijuana is about more - much more - than recreational use. In fact, its medicinal potential, unchained, could be worth billions more than the billion-dollar consumables market. Study after study has shown that up to two dozen medical conditions could be treated with marijuana. Two of its more intriguing components, non-psychoactive cannabidiol (CBD) and psychoactive tetrahydrocannabinol (THC), have a clear impact on brain function and pain management. Glaucoma sufferers, for example, have long known that pot can reduce ocular swelling. Many people swear by pot's ability to improve lung function, counterintuitive as that may seem. And people suffering from conditions such as multiple sclerosis will tell you that this drug can greatly ease the daily pain they must live with. Results like those are part of the reason medical marijuana has been approved in 24 states and in many countries around the world - and the reason why the medical marijuana market topped $4 billion in 2015. Just one company, a biotech that first hit my radar in 2014 and has delivered peak gains of more than 1,100% over the past three years, is favorably positioned to make a classic "corner-the-market" move on this incredibly lucrative segment. I'm recommending it once more today, after a round of quadruple-digit gains, because I think there's every reason for it to happen all over again... Tags: marijuana To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post The "Pfizer of Medical Marijuana" Could Be In for Another Round of 1,000%+ Gains appeared first on Money Morning - We Make Investing Profitable .